Pharmacotherapy for depressed pregnant women: overcoming obstacles to gathering essential data.

Full Abstract

Approximately 3% of pregnant women take antidepressant medications. Information on the impact of antidepressants on short- and long-term maternal and offspring outcomes is highly desirable but neglected. The position that the dearth of treatment information is of greater concern than the risks to pregnant subjects involved in medical research is gaining support. Mandating the collection of reproductive outcome data in exposed childbearing women is an overdue step toward societal responsibility to our most vulnerable members.

Author information

Author/s: Wisner, K L (KL); Appelbaum, P S (PS); Uhl, K (K); Goldkind, S F (SF);

Affiliation: Departments of Psychiatry, Obstetrics, Gynecology and Reproductive Sciences, Epidemiology, and Women's Studies, Pittsburgh, Pennsylvania, USA. wisnerkl(-atsign-)upmc.edu

Journal and publication information

Publication Type: Journal Article

Journal: Clinical pharmacology and therapeutics (Clin Pharmacol Ther), published in United States. (Language: eng)

Reference: 2009-Oct; vol 86 (issue 4) : pp 362-5

Dates: Created 2009/09/18; Completed 2009/10/09;

PMID: 19763116, status: MEDLINE (last retrieval date: 10/9/2009, IMS Date: )

Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.

External Links for this article
(including full text providers, if available):

Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.

This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.